SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

Oculis Reports Third-Quarter 2026 Financial Results

Oculis announced its third-quarter 2026 financial results; the available report excerpt provides no financial figures.

OCS
SquawkNews Desk 1 updates Updated Nov 03, 2026, 09:09 PM UTC

Story updates

09:09:17 PM UTC
SquawkNews
Oculis birtir uppgjör fyrir þriðja ársfjórðung 2026 og stefnir að mikilvægum áföngum í lyfjaþróun á

ZUG, Switzerland, November 3, 2026 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq: OCS / XICE: OCS) (Oculis), a global biopharmaceutical company focused on breakthrough innovations to address significant unmet medical needs in neuro-ophthalmology and ophthalmology, today announced results for the th…

Related stories

Mosaic Reports Q3 Loss as Net Sales Decline Year Over Year Mosaic reported a net loss in Q3 2026, while net sales declined year over year. M impact | EQUITY | Nov 03, 2026, 10:28 PM UTC Fairfax Financial Q3 Net Earnings Fall on Investment Losses M impact | EQUITY | Nov 03, 2026, 10:26 PM UTC Aquestive Therapeutics Q3 2026 Revenue Falls to $7.6 Million M impact | EQUITY | Nov 03, 2026, 10:14 PM UTC AH Realty Trust Secures $550 Million Facility and $221.8 Million in Loans AH Realty Trust entered into a $550 million credit facility, a separate $100 million seven-year term loan and a $121.8 million loan secured by Constellation Tower. The facilities r M impact | EQUITY | Nov 03, 2026, 10:13 PM UTC Mosaic Swings to Q3 2026 Net Loss of $72 Million Mosaic reported a net loss of $72 million in Q3 2026, compared with a profit a year earlier. M impact | EQUITY | Nov 03, 2026, 10:13 PM UTC Booking Holdings Reports a Third-Quarter Loss After FTC Action Booking Holdings reported a loss in its third-quarter results following action by the FTC. M impact | EQUITY | Nov 03, 2026, 10:13 PM UTC